A concave structure interlayer coupled iron diatomic nanozyme and its preparation method and application

Through the design and preparation of interlayer coupling iron diatomic nanoenzymes, the problem of insufficient catalytic performance of single-atomic nanoenzymes is solved, efficient bactericidal and antibacterial effects are achieved, and local thermal therapy is provided in infected wound sites to promote healing .

CN117718067BActive Publication Date: 2024-11-26NANFANG HOSPITAL OF SOUTHERN MEDICAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202311487463.0
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-11-08
Publication Date
2024-11-26
Estimated Expiration
2043-11-08

AI Technical Summary

Technical Problem

The existing single-atom nanoenzymes have a single type, a single structure, and a small metal load, resulting in limited catalytic performance, making it difficult to effectively kill bacteria and provide anti-tumor effects.

Method used

Design a concave structure and interlayer coupled iron dia nanoenzyme, prepared by high-temperature calcination of zeolite imidazole backbone material and iron dimer, forming a coupled iron dia structure, enhancing metal loading and catalytic activity, and combining laser irradiation to produce Photothermal effect.

Benefits of technology

It has achieved efficient catalyzing the production of hydroxyl radicals by hydrogen peroxide, significantly improving antibacterial activity and catalytic efficiency, providing broad-spectrum antibacterial activity, and producing local thermal therapy effects on infected wound sites to promote healing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117718067B_ABST
    Figure CN117718067B_ABST
Patent Text Reader

Abstract

The present invention discloses a concave structure interlayer coupled iron diatomic nanozyme and its preparation method and application, belonging to the field of nanomaterial technology. The concave structure interlayer coupled iron diatomic nanozyme provided by the present invention includes a zeolite imidazolate framework material pyrolysis product and a coupled iron diatomic structure; the pyrolysis product is a cubic structure with each face being concave, and has at least two layers of layered structure, and the layered structure is composed of C atoms and N atoms; the coupled iron diatomic structure is distributed between adjacent layered structures of the pyrolysis product, and is formed by combining the N atoms in the pyrolysis product with the two coupled iron atoms. The nanozyme of the present invention has an interlayer coupled iron diatomic structure, has excellent enzyme catalytic performance, and the diatomic structure can also solve the singleness problem of single-atom nanozymes and increase the diversity of nanozyme structures; and the nanozyme is a concave structure, which is conducive to fully exposing the metal atom active sites and improving the catalytic efficiency.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of nanomaterials, and in particular relates to a concave structure interlayer coupled iron diatomic nanozyme and a preparation method and application thereof. Background Art

[0002] Nanozymes are nanomaterials with enzyme-like properties. They have been widely used in the biological field and have achieved good therapeutic effects. In the preparation process of nanozymes, different chemical principles, synthesis methods and structural morphology will affect its activity. Currently, the reported enzyme-like activities include peroxidase (POD), catalase (CAT), oxidase (OXD), superoxide dismutase (SOD), etc. Among them, POD-like activity can catalyze hydrogen peroxide to produce a large number of hydroxyl groups, and finally generate a large number of reactive oxygen species (superoxide anions, hydroxyl radicals, etc.) through a series of cascade catalytic reactions in the weak acid microenvironment of the tumor. Combined with excellent photothermal performance, it exerts anti-tumor effects both in vitro and in vivo.

[0003] Studies have reported many single-atom nanozymes that can exert excellent catalytic activity and have good anti-tumor effects, but single-atom nanozymes still have certain limitations: first, the types of single-atom nanozymes are single, mainly manganese, iron, zinc, cobalt, and copper-based nanozymes, and other single-atom nanozymes are rarely reported; second, the structure of single-atom nanozymes is single, mainly MNC structure; finally, the metal loading of single-atom nanozymes is small, which affects the improvement and enhancement of their enzyme catalytic performance, further limiting the application of single-atom nanozyme technology. In addition, nanozymes with single catalytic performance will have the disadvantage of poor therapeutic effect. Therefore, it is necessary to design a nanozyme that has both POD-like activity and excellent photothermal performance. Summary of the invention

[0004] In order to overcome the problems existing in the above-mentioned prior art, one of the objects of the present invention is to provide a concave structured interlayer coupled iron diatomic nanozyme, which can catalyze the substrate hydrogen peroxide to produce abundant hydroxyl radicals through a peroxidase-like action, which is used to kill Gram-positive cocci and Gram-negative bacilli; in addition, combined with laser irradiation, the photothermal effect produced by the nanozyme can produce local hyperthermia on the infected wound site, thereby effectively eradicating bacteria and providing broad-spectrum antibacterial activity.

[0005] The second object of the present invention is to provide a method for preparing the above-mentioned concave structure interlayer coupled iron diatomic nanozyme.

[0006] A third object of the present invention is to provide a method for catalytic decomposition of peroxide.

[0007] A fourth object of the present invention is to provide a wound repair material.

[0008] In order to achieve the above object, the technical solution adopted by the present invention is:

[0009] The first aspect of the present invention provides a concave structure interlayer coupled iron diatomic nanozyme, comprising a zeolite imidazolate framework material pyrolysis product and a coupled iron diatomic structure;

[0010] The pyrolysis product is a cubic structure with each face being concave, and has at least two layers of layered structures, wherein the layered structures are composed of C atoms and N atoms;

[0011] The coupled iron diatomic structure is distributed between adjacent layered structures of the pyrolysis product, and is formed by the combination of a N atom in the pyrolysis product and two coupled iron atoms.

[0012] The nanozyme of the present invention has a bimetallic atom pair with good electronic structure and geometric structure. While increasing the metal loading, the strong interaction between the biatoms and the carrier can simulate the special catalytic activity of binuclear organisms, further improving the enzyme-like catalytic performance; the biatomic structure can also solve the singleness problem of single-atom nanozymes, increase the diversity of nanozyme structures, thereby solving the technical defects of existing nanozymes and having more application prospects. The concave structure is conducive to fully exposing the active sites of metal atoms, making its atomic utilization efficiency the highest and providing catalytic efficiency; and the concave structure increases the atomic density while being conducive to the generation of coupling effects.

[0013] Preferably, in the nanozyme, the distance between the two coupled iron atoms is 0.1 to 0.4 nm; more preferably, it is 0.2 to 0.3 nm.

[0014] Preferably, in the nanozyme, each iron atom is coordinated with 3 to 5 N atoms. In a specific embodiment of the present invention, each iron atom is coordinated with 4 N atoms.

[0015] That is to say, in the nanozyme, the coupled iron diatomic structure is N x -Fe-Fe-N x There exists a structure of , x is 3-5, and further, x is 4.

[0016] Preferably, the particle size of the nanozyme is 200-400 nm; more preferably, 250-350 nm.

[0017] The second aspect of the present invention provides a method for preparing the concave structure interlayer coupled iron diatomic nanozyme described in the first aspect of the present invention, comprising the following steps: high-temperature calcining the zeolite imidazolate framework material and the iron dimer to obtain the concave structure interlayer coupled iron diatomic nanozyme.

[0018] In the preparation method of the present invention, the zeolite imidazolate framework material with a cubic structure and the iron dimer are calcined at high temperature. The iron dimer can not only provide an iron source to form an interlayer coupled iron diatomic structure, but also release carbon-containing gas to form a shear force, thereby promoting the cubic structure to form a concave structure.

[0019] In a specific embodiment of the present invention, the zeolite imidazolate framework material is selected from ZIF-8.

[0020] Preferably, in the preparation method, the iron dimer includes at least one of m-tetraphenylporphine-M-iron oxide dimer, dicarbonylcyclopentadienyl iron dimer, cyclopentadienyl iron dicarbonyl dimer or (η5-cyclopentadienyl) iron dicarbonyl dimer. In a specific embodiment of the present invention, the iron dimer is selected from cyclopentadienyl iron dicarbonyl dimer.

[0021] Preferably, in the preparation method, the mass ratio of the zeolite imidazolate framework material to the iron dimer is 1:(0.5-2); more preferably 1:(0.8-1.8); and even more preferably 1:(1-1.5).

[0022] Preferably, in the preparation method, the temperature of the high temperature calcination is 900-1000°C; more preferably, it is 920-980°C.

[0023] Preferably, in the preparation method, the high-temperature calcination time is 2 to 4 hours; more preferably, it is 2.5 to 3.5 hours.

[0024] The third aspect of the present invention provides a method for catalytic decomposition of peroxides, wherein the method uses the concave structure interlayer coupled iron diatomic nanozyme described in the first aspect of the present invention as a catalyst to catalyze the decomposition of peroxides.

[0025] Preferably, the catalysis is carried out at a pH of 3-6; more preferably, the pH is 4-5.

[0026] Preferably, the catalysis is carried out at a temperature of 30-50°C; more preferably, the temperature is 35-45°C.

[0027] The fourth aspect of the present invention provides a wound repair material, comprising the concave structure interlayer coupled iron diatom nanozyme described in the first aspect of the present invention.

[0028] The beneficial effects of the present invention are as follows: the nanozyme of the present invention has an interlayer coupled iron diatomic structure, has excellent enzyme catalytic performance, and the diatomic structure can also solve the singleness problem of single-atom nanozymes and increase the diversity of nanozyme structures; and the nanozyme has a concave structure, which is conducive to fully exposing the metal atom active sites and improving the catalytic efficiency. The nanozyme can catalyze the substrate hydrogen peroxide to produce abundant hydroxyl radicals through a peroxidase-like action, and has high bactericidal activity; in addition, combined with laser irradiation, the photothermal effect produced by the nanozyme can produce local hyperthermia on the infected wound site, thereby effectively eradicating bacteria and providing broad-spectrum antibacterial activity. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 It is the SEM picture of ZIF-8 of the embodiment of the present invention.

[0030] Figure 2 This is a SEM image of the ZIF-8 pyrolysis product N-CC according to an embodiment of the present invention.

[0031] Figure 3 This is a SEM image of IC-DAN according to an embodiment of the present invention.

[0032] Figure 4 The STEM image (a) and the local enlarged image (b) of the IC-DAN according to the embodiment of the present invention.

[0033] Figure 5 Elemental analysis diagram of IC-DAN according to an embodiment of the present invention.

[0034] Figure 6 Fe K-edge XANES spectra of IC-DAN of the embodiment of the present invention and the reference sample.

[0035] Figure 7 is the Fourier transform amplitude of the Fe K-edge XANES signal of the IC-DAN of the embodiment of the present invention and the reference sample.

[0036] Figure 8 It is the Fe K-edge wavelet transform (WT) spectrum of IC-DAN of the embodiment of the present invention and the reference sample.

[0037] Fig. 9 Fitting curves of EXAFS in k-space of SAN (a), IC-DAN (b) and both (c).

[0038] Fig.10 Fitting curves of EXAFS in r-space of SAN (a), IC-DAN (b) and both (c).

[0039] Fig.11Aberration-corrected HAADF-STEM image (a) and local magnification (b) of the coupled iron atoms.

[0040] Fig.12 is the intensity distribution of coupled iron atoms.

[0041] Fig.13 Schematic diagram of the structure of IC-DAN according to an embodiment of the present invention, (a) top view; (b) side view.

[0042] Fig.14 Schematic diagram of the catalytic decomposition process of peroxide by IC-DAN according to an embodiment of the present invention.

[0043] Fig.15 Graph showing the free energy change of IC-DAN according to an embodiment of the present invention.

[0044] Fig.16 Density of states diagram of FeN4 single-atom enzyme (a) and FeN4-FeN4 diatomic enzyme (b).

[0045] Fig.17 This is the steady-state kinetic analysis diagram of the generation of ·OH at different TMB concentrations.

[0046] Fig.18 This is the steady-state kinetic analysis diagram of the generation of ·OH under different H2O2 concentrations.

[0047] Fig.19 IC-DAN (20 μg·mL -1 ) and H2O2 (100μM) catalyzed TMB color development curve.

[0048] Fig. 20 IC-DAN (20 μg·mL -1 ) and H2O2 (100 μM) catalyzed TMB color development curve.

[0049] Fig.21 Electron spin resonance spectra of ·OH generated by the conversion of H2O2 under different conditions.

[0050] Fig. 22 Infrared images and corresponding temperatures at different IC-DAN concentrations.

[0051] Fig.23 These are photos of agar plates after inoculation of E. coli and S. aureus under different treatment conditions.

[0052] Fig.24 The bacterial activity after inoculation of E. coli and S. aureus under different treatment conditions.

[0053] Fig.25 Photos of agar plates after inoculation of MRSA and MREC under different treatment conditions.

[0054] Fig.26 Bacterial activity after inoculation of MRSA and MREC under different treatment conditions.

[0055] Fig. 27 These are images of MRSA bacteria stained with different stains under different treatment conditions.

[0056] Fig.28 SEM images of MRSA and MREC bacteria under different treatment conditions.

[0057] Fig.29 Schematic diagram of the IC-DAN anti-infection treatment regimen used after MRSA infection of normal mice.

[0058] Fig.30 These are photos of wounds on normal mice infected with MRSA.

[0059] Fig.31 Relative wound healing area of ​​normal mice infected with MRSA.

[0060] Fig.32 Schematic diagram of the anti-infection treatment regimen used after MRSA infection in type 2 diabetic mice.

[0061] Fig.33 These are photos of wounds in type 2 diabetic mice infected with MRSA.

[0062] Fig.34 Relative wound healing area of ​​type 2 diabetic mice infected with MRSA. DETAILED DESCRIPTION

[0063] The content of the present invention is further described in detail below through specific examples. It should also be understood that the following examples are only used to further illustrate the present invention and cannot be construed as limiting the scope of protection of the present invention. Some non-essential improvements and adjustments made by those skilled in the art based on the principles set forth in the present invention all belong to the scope of protection of the present invention. The specific process parameters and the like in the following examples are also only examples within a suitable range, that is, those skilled in the art can make a selection within a suitable range through the description herein, and are not limited to the specific data exemplified below. The raw materials, reagents or devices used in the following examples and comparative examples, unless otherwise specified, can all be obtained from conventional commercial sources, or can be obtained by existing known methods.

[0064] Example

[0065] This example provides a concave structure interlayer coupling diatomic nanozyme (IC-DAN), which is prepared by a method comprising the following steps:

[0066] 1) Preparation of ZIF-8 nanocubes: First, accurately weigh 5.65 g of 2-methylimidazole (2-MIM) and fully dissolve it in 80 mL of ultrapure water. Secondly, accurately weigh 0.365 g of zinc nitrate (Zn(CH3COO)2) and dissolve it in 20 mL of ultrapure water. Finally, quickly add the zinc nitrate solution to the 2-MIM solution and continue to stir vigorously at room temperature until the solution becomes white and turbid. Next, centrifuge the solution (8000 g, 5 min), wash it alternately with ultrapure water and methanol solution several times, and finally set the temperature of the vacuum drying oven to 65 ° C to dry the product to obtain ZIF-8 nanocubes for use.

[0067] 2) Preparation of IC-DAN: First, accurately weigh 0.4g of ZIF-8 powder and place it in a quartz boat, then weigh 0.5g of cyclopentadienyl dicarbonyl iron dimer ([C5H5Fe(CO)2]2) and place it on top of the ZIF-8 powder, seal the quartz boat and place it in a high-temperature tube furnace, then set the temperature of the tube furnace to 950℃, sinter at high temperature for 3h and then cool naturally. Then wash the product at 80℃ for 12h with a 0.5M sulfuric acid solution prepared in advance to remove unreacted impurities, and finally vacuum dry the product and calcine it again under the same conditions. The resulting black powder is IC-DAN (IC-DAN needs to be sealed and stored under vacuum drying conditions).

[0068] Comparative Example 1

[0069] In this example, the ZIF-8 nanocubes obtained in step 1) of the embodiment were sintered at 950° C. for 3 h to obtain the ZIF-8 thermal decomposition product N-CC.

[0070] Comparative Example 2

[0071] This example provides an iron single-atom nanozyme (SAN), which is prepared by a method comprising the following steps:

[0072] 1) Preparation of ZIF-8 nanocubes: First, accurately weigh 5.65 g of 2-methylimidazole (2-MIM) and fully dissolve it in 80 mL of ultrapure water. Secondly, accurately weigh 0.365 g of zinc nitrate (Zn(CH3COO)2) and dissolve it in 20 mL of ultrapure water. Finally, quickly add the zinc nitrate solution to the 2-MIM solution and continue to stir vigorously at room temperature until the solution becomes white and turbid. Next, centrifuge the solution (8000 g, 5 min), wash it alternately with ultrapure water and methanol solution several times, and finally set the temperature of the vacuum drying oven to 65 ° C to dry the product to obtain ZIF-8 nanocubes for use.

[0073] 2) Preparation of SAN: First, accurately weigh 0.4g of ZIF-8 powder and place it in a quartz boat, then weigh 0.3g of cyclopentadienyl dicarbonyl iron dimer ([C5H5Fe(CO)2]2) and place it on top of the ZIF-8 powder, seal the quartz boat and place it in a high-temperature tube furnace, then set the temperature of the tube furnace to 950°C, sinter at high temperature for 3h and then cool naturally. Then wash the product at 80°C for 12h with a 0.5M sulfuric acid solution prepared in advance to remove unreacted impurities, and finally vacuum dry the product and calcine it again under the same conditions. The resulting black powder is SAN (SAN needs to be sealed and stored under vacuum drying conditions).

[0074] The structures of ZIF-8, IC-DAN in the examples and N-CC in comparative example 1 were analyzed respectively. Figure 1 It is the SEM picture of ZIF-8 of the embodiment of the present invention, Figure 2 This is a SEM image of the ZIF-8 pyrolysis product N-CC of the embodiment of the present invention, Figure 3 This is a SEM image of IC-DAN according to an embodiment of the present invention. Figures 1 to 3 Analysis shows that the ZIF-8 synthesized in the embodiment has a nanocube structure, and the ZIF-8 pyrolysis product N-CC inherits the nanocube structure of ZIF-8, but the nanocube is much smaller; after doping with diiron using cyclopentadienyl dicarbonyl dimer as a precursor, the morphology of the prepared catalyst has changed significantly. Although IC-DAN still presents a cubic form as a whole, each face of the cube is concave, and IC-DAN is significantly larger than N-CC and ZIF-8 cubes, which indicates that the introduction of cyclopentadienyl dimer during gas doping causes the expansion and morphological change of the cube, resulting in a material with a richer porous structure.

[0075] Figure 4 The STEM image (a) and the local enlarged image (b) of the IC-DAN of the embodiment of the present invention are shown in FIG. Figure 5 Elemental analysis diagram of IC-DAN of the embodiment of the present invention. Figure 4The scanning transmission electron microscope (STEM) image shown in a shows that at the atomic scale, the doped iron is highly dispersed in the material and no iron nanoparticles are observed, indicating that the gas doping strategy adopted in the present invention achieves good iron dispersion and doping; Figure 4 As shown in the enlarged image (b), all the iron atoms (bright spots) are distributed on the atomic scale, and each region has obvious coupled iron atoms. The distance between two coupled iron atoms is about 0.26nm, indicating that in the final prepared ZIF-8 pyrolysis product, cyclopentadiene dimer was used as an iron precursor to achieve the preparation of concave coupled iron structure. And each iron atom combines with a N atom to form an "N x -Fe-Fe-N x "The electronic structure of Figure 5 The elemental analysis map of IC-DAN shown further reveals that Fe and N are uniformly distributed in the ZIF-8 derived carbon framework.

[0076] In order to further understand the local atomic coordination of IC-DAN, X-ray absorption fine structure spectroscopy (EXAFS) analysis and X-ray absorption spectroscopy (XAS) analysis were carried out using Fe foil, Fe3O4, FePc (iron particles) and several SAN as reference samples.

[0077] Figure 6 Fe K-edge XANES spectra of IC-DAN and reference samples of the present invention, from Figure 6 It can be seen that the spectrum of IC-DAN is significantly different from that of iron foil and Fe2O3, but similar to the spectra of SAN and FePc samples, indicating that there are almost no iron particles or iron oxides in the sample and almost all the doped iron atoms are coordinated with nitrogen.

[0078] Figure 7 is the Fourier transform amplitude of the Fe K-edge XANES signal of the IC-DAN of the embodiment of the present invention and the reference sample, from Figure 7 It can be seen that the main peak of IC-DAN is located at At about An obvious Fe-Fe peak appears at , proving that iron is dispersed in the nitrogen-doped carbon material in the form of coupled iron atoms.

[0079] Figure 8 The Fe K-edge wavelet transform (WT) spectra of IC-DAN and reference samples of the present invention are shown in Figure 1. Figure 8 It can be seen that IC-DAN exhibits enhanced Fe-Fe bonding.

[0080] Fig. 9The fitting curves of EXAFS in k-space of SAN (a), IC-DAN (b) and both (c) are shown. Fig.10 The EXAFS fitting curves of SAN (a), IC-DAN (b) and both (c) in r-space. In comparison, the absorption edge of IC-DAN moves toward a lower energy direction than SAN, indicating the presence of paired iron atoms. Combining the EXAFS fitting results and WT analysis, it can be seen that the number of coordination bonds between N and iron in IC-DAN is about 4, which further indicates that the doped coupled iron atoms exist in the catalyst in the N4-Fe-Fe-N4 active structure, thereby greatly enhancing the catalytic performance.

[0081] The coupled iron atoms were further characterized and analyzed. Fig.11 Aberration-corrected HAADF-STEM image (a) and local magnification (b) of coupled iron atoms. Fig.12 is the intensity distribution diagram of coupled iron atoms, where 1 and 2 are Fig.11 The two pairs of coupled iron atoms are marked in Figures 11-12 It can be further concluded that iron exists in the form of coupled iron atoms, and the distance between two coupled iron atoms is about 0.25 to 0.27 nm.

[0082] According to the above analysis, the structure diagram of IC-DAN can be obtained, as shown in Fig.13 , which is a schematic diagram of the structure of IC-DAN according to an embodiment of the present invention, (a) a top view; (b) a side view, in which an iron atom is combined with four N atoms, and two iron atoms between two adjacent layers are coupled.

[0083] Application Example 1

[0084] IC-DAN is used as a POD-like catalyst to provide a catalytic decomposition method for peroxides.

[0085] 1. Catalytic mechanism

[0086] Density functional theory was used to calculate the free energy diagrams of diatomic peroxidases and their intermediates (O*, *OH, ·OH, and *OOH). Fig.14 This is a schematic diagram of the catalytic decomposition process of peroxide by IC-DAN according to an embodiment of the present invention. Fig.15 This is the IC-DAN free energy change diagram of an embodiment of the present invention, Fig.16 Density of states (DOS) diagrams of FeN4 single-atom enzyme (a) and FeN4-FeN4 diatomic enzyme (b).

[0087] from Figures 14-15 The catalytic decomposition process of peroxide was analyzed, namely: (i) the FeN4-FeN4 structure in IC-DAN adsorbed the substrate hydrogen peroxide; Fig.15It can be seen that the adsorption energies of FeN4-FeN4 and FeN4 for H2O2 are 0.49 and 0.55 eV respectively. Due to the lower adsorption energy, the FeN4-FeN4 structure is more likely to adsorb and bind to H2O2 molecules; (ii) the adsorbed H2O2 undergoes homolysis to form two *OH; (iii) the *OH on a single Fe site undergoes desorption; this is the key step in determining the catalytic rate. Fig.15 It can be seen that the free energy changes of FeN4-FeN4 and FeN4 in this stage are 0.49 and 0.75 eV respectively, which shows that the energy barrier of FeN4-FeN4 is lower, which is more conducive to the formation of *OH; (iv) Under acidic conditions, H + It can combine with *OH to generate *H2O; (v) Finally, both FeN4 and FeN4-FeN4 return to the initial state of H2O2 molecule desorption.

[0088] like Fig.16 As shown, compared with the FeN4 single-atom enzyme, the DOS of the FeN4-FeN4 diatomic enzyme is significantly higher when close to the Fermi level, and more new hybrid electronic states can be observed, which proves the stronger interaction and adsorption between the FeN4-FeN4 diatomic enzymes and the enhancement of charge transfer during peroxidase catalysis.

[0089] 2. Factors affecting catalytic activity

[0090] Peroxidase (POD) is an enzyme that can effectively catalyze the conversion of H2O2 into ·OH. The 3,3',5,5'-tetramethylbenzidine (TMB) method was used to explore the effects of pH, temperature, IC-DAN concentration, substrate H2O2 concentration and probe TMB concentration on the activity of IC-DAN-type POD. Fig.17 This is the steady-state kinetic analysis diagram of the generation of ·OH at different TMB concentrations. Fig.18 The steady-state kinetic analysis diagram of the generation of ·OH under different H2O2 concentrations shows that IC-DAN incubated with H2O2 can produce cytotoxic substances ·OH and oxidize colorless TMB to blue TMB.

[0091] Since the acidity of infected wound tissue is generally higher than that of normal tissue, the catalytic activity at different pH values ​​was also measured. Fig.19 IC-DAN (20 μg·mL -1 ) and H2O2 (100μM) catalyzed TMB color development curve, Fig. 20 IC-DAN (20 μg·mL -1) and H2O2 (100 μM) catalyzed the relative absorbance of TMB color curve. The results showed that the catalytic effect of IC-DAN under weakly acidic conditions (pH = 4) was significantly enhanced than that under neutral conditions. When the reaction temperature was changed, the results showed that the POD-like activity of IC-DAN was optimal at 40°C.

[0092] Fig.21 The electron spin resonance (ESR) spectra of H2O2 converted to ·OH under different conditions. The experimental results show that when 100 μM H2O2 is added, the signal intensity of ·OH in IC-DAN is significantly enhanced, proving that IC-DAN can catalyze the decomposition of H2O2 to generate ·OH.

[0093] Application Example 2

[0094] In this case, IC-DAN was used as a wound repair material to verify its photothermal effect, antibacterial activity and wound repair performance.

[0095] 1. In vitro photothermal effect (PTT)

[0096] The photothermal effect of IC-DAN was studied by 808nm near-infrared laser. The temperature change of IC-DAN under different concentrations and power densities was studied by infrared imaging technology. Fig. 22 The infrared images and corresponding temperatures at different IC-DAN concentrations show that when the IC-DAN concentration is 20 μg / mL and the 808 nm NIR laser power density is 0.8 W·cm -2 When the solution temperature rises rapidly to 43.8 °C, it can be seen that IC-DAN has excellent photothermal conversion ability.

[0097] 2. In vitro antibacterial activity (POD-like activity)

[0098] In view of the above-mentioned photothermal conversion ability and POD-like activity, a combined antibacterial effect mediated by PTT and POD-like was proposed. Therefore, the antibacterial ability of IC-DAN was further evaluated in vitro. E. coli (Escherichia coli), S. aureus (Staphylococcus aureus), MRSA (methicillin-resistant Staphylococcus aureus) and MREC (multidrug-resistant Escherichia coli) were used to study the antibacterial effect of IC-DAN. After different treatments, the bacterial suspension was continuously diluted on LB agar for 16h.

[0099] Fig.23 These are photos of agar plates inoculated with E.coli and S.aureus under different treatment conditions. Fig.24 The bacterial activity after inoculation of E. coli and S. aureus under different treatment conditions; Fig.25 These are photos of agar plates inoculated with MRSA and MREC under different treatment conditions. Fig.26 The bacterial activity after inoculation of MRSA and MREC under different treatment conditions. Figures 23-26 The results showed that the number of bacterial colonies in the IC-DAN alone treatment group showed that the remaining bacterial activities of MREC and MRSA were 64.92% and 53.67%, respectively. It was speculated that the antibacterial effect was due to the peroxidase catalysis of IC-DAN. To verify this, H2O2 (2100 μM) was added to the bacterial suspension, and it was indeed observed that the remaining bacterial activities of MREC and MRSA decreased to 57.53% and 41.28%, respectively. In the NIR irradiation group (IC-DAN+NIR irradiation group), the temperature of the bacterial suspension increased rapidly within 5 minutes after laser irradiation, and the remaining bacterial activities of MREC and MRSA were 39.81% and 28.84%, respectively, indicating that IC-DAN has a certain photothermal therapy (PTT) ability. In particular, after the combined treatment of IC-DAN, H2O2 and NIR irradiation, the antibacterial effect can be achieved at a high number (108 CFU mL -1 ) All bacteria were completely eradicated under the above conditions. The above results indicate that IC-DAN exhibits excellent antibacterial ability when it has both peroxidase-like activity and thermotherapy activity.

[0100] Then, the antibacterial activity of IC-DAN was evaluated by fluorescence microscopy. In this experiment, a live / dead dual-color fluorescent staining kit was used to distinguish the in vitro antibacterial activity, in which SYTO9 can stain all cells and show green fluorescence under 488nm excitation, while propidium iodide (PI) can only penetrate dead cells and show red fluorescence under 561nm excitation. Fig. 27 The following are pictures of MRSA bacteria stained with different stains under different treatment conditions. Fig. 27 It can be seen that when treated with IC-DAN alone, most bacteria showed green fluorescence; for the "IC-DAN+H2O2" or "IC-DAN+NIR" groups, a small number of bacteria showed red fluorescence, which was attributed to the single POD-like activity or photothermal effect of IC-DAN, while the "IC-DAN+H2O2+NIR" group showed strong red fluorescence, indicating that the synergistic effect of IC-DAN's POD-like activity and photothermal activity caused significant damage to the bacteria. These results are in good agreement with the results of the in vitro antibacterial experiment. In summary, the in vitro experimental results show that IC-DAN has strong antibacterial ability.

[0101] To further explore the antibacterial mechanism of IC-DAN, the structural integrity of the bacterial membrane against MREC and MRSA was examined by SEM. Fig.28Figure 2 shows the SEM images of MRSA and MREC bacteria under different treatment conditions. In the control group, the complete rod-shaped structure of MREC bacteria and the complete spherical structure of MRSA bacteria were observed; after treatment with IC-DAN, the integrity of the bacterial cell membrane was slightly damaged, indicating that IC-DAN nanomaterials alone were not sufficient to cause extensive damage to the integrity of the bacterial membrane; however, under H2O2 and NIR laser irradiation, after IC-DAN treatment, the cell membranes of MREC and MRSA were severely damaged, accompanied by obvious shrinkage, and collapse and cracks were visible on the cell membrane surface. Therefore, it can be concluded that IC-DAN destroys the bacterial membrane through NIR-mediated photothermal action and H2O2-enhanced POD-like activity, thereby producing a rapid bactericidal effect.

[0102] 3. In-vivo wound repair

[0103] Given that IC-DAN has good antibacterial ability in vitro, the therapeutic effect of IC-DAN on infected wounds of normal mice and type 2 diabetic mice was further studied. After the infected diabetic mice were successfully constructed, these mice were randomly divided into 5 groups, including: G1 group, control group; G2 group, IC-DAN; G3 group, IC-DAN+H2O2; G4 group, IC-DAN+NIR; G5 group, IC-DAN+H2O2+NIR. To observe the healing effect of the infected wound, the area of ​​the bacterial infection site was monitored every 3 days. Fig.29 Schematic diagram of IC-DAN anti-infection treatment scheme used after MRSA infection in normal mice; Fig.30 This is a photo of the wound surface of a normal mouse infected with MRSA (scale bar 5 nm); Fig.31 is the relative wound healing area of ​​normal mice infected with MRSA (n=5); Fig.32 Schematic diagram of the anti-infection treatment plan used after MRSA infection in type 2 diabetic mice; Fig.33 This is a photo of the wound surface of type 2 diabetic mice infected with MRSA; Fig.34 Relative wound healing area of ​​type 2 diabetic mice infected with MRSA (n=5). ****p<0.0001, ***p<0.001, **p<0.01, *p<0.05.

[0104] Taking the type 2 diabetes mouse model as an example, the mice in the G5 group (IC-DAN+H2O2+NIR) were almost completely healed on the 13th day, while the other groups were only partially healed, and the control group still had obvious wound scars. According to statistical analysis, the relative unhealed wound area of ​​the G5 group reached 14.51% of the initial size, while the G4 group reached 24.36%, the G3 group reached 22.82%, the G2 group reached 28.07%, and the G1 group reached 65.62%. In addition, relevant results showed that the wound healing speed of the G5 group was significantly faster than that of the other groups, especially compared with the mice in the G1 group.

[0105] Among normal mice infected with MRSA, the wounds in group G5 (IC-DAN+H2O2+NIR) healed the fastest. At the same time, after treatment, the intelligence and weight of mice in group G5 were better than those in other groups, and the healing time was shorter than that of mice with type 2 diabetes. Comparing the healing process of infected wounds in normal mice and diabetic mice, it can be seen that the wound healing period of diabetic mice was longer (about 13 days) and the weight of mice was lower. This phenomenon is also consistent with the fact that the wound healing speed of diabetic patients is much lower than that of non-diabetic patients.

[0106] In addition, IC-DAN has good biocompatibility and biosafety.

[0107] Comprehensive antibacterial effects show that IC-DAN has great application potential in clinical antibacterial and has wide application in the preparation of wound repair materials.

[0108] The nanozyme of the present invention has an interlayer coupled iron diatomic structure, has excellent enzyme catalytic performance, and the diatomic structure can also solve the single problem of single-atom nanozymes, increase the diversity of nanozyme structures; and the nanozyme has a concave structure, which is conducive to fully exposing the metal atom active sites and improving the catalytic efficiency. The nanozyme can catalyze the substrate hydrogen peroxide to produce abundant hydroxyl radicals through a peroxidase-like action, and has high bactericidal activity; in addition, combined with laser irradiation, the photothermal effect produced by the nanozyme can produce local hyperthermia on the infected wound site, thereby effectively eradicating bacteria and providing broad-spectrum antibacterial activity.

Claims

1. A concave structure interlayer coupled iron diatomic nanozyme, characterized in that: including zeolite imidazolate framework material pyrolysis products and coupled iron diatomic structures; The pyrolysis product is a cubic structure with each face being concave, and has at least two layers of layered structures, wherein the layered structures are composed of C atoms and N atoms; The coupled iron diatomic structure is distributed between adjacent layered structures of the pyrolysis product and is formed by the combination of the N atom in the pyrolysis product and the two coupled iron atoms; The concave structure interlayer coupled iron diatomic nanozyme is prepared by a method comprising the following steps: high-temperature calcining of a zeolite imidazolate framework material and an iron dimer to obtain the concave structure interlayer coupled iron diatomic nanozyme.

2. The concave structure interlayer coupled iron diatomic nanozyme according to claim 1, characterized in that: The distance between the two coupled iron atoms is 0.1-0.4 nm.

3. The concave structure interlayer coupled iron diatomic nanozyme according to claim 1, characterized in that: Each iron atom is coordinated with four N atoms.

4. The method for preparing the concave structure interlayer coupled iron diatomic nanozyme according to any one of claims 1 to 3, characterized in that: The method comprises the following steps: calcining the zeolite imidazolate framework material and the iron dimer at high temperature to obtain the concave structure interlayer coupled iron diatomic nanozyme.

5. The preparation method according to claim 4, characterized in that: The zeolite imidazolate framework material is selected from ZIF-8; And / or, the iron dimer includes at least one of m-tetraphenylporphine-M-iron oxide dimer, dicarbonylcyclopentadienyl iron dimer, cyclopentadienyl dicarbonyl iron dimer or (η5-cyclopentadienyl) dicarbonyl iron dimer.

6. The preparation method according to claim 4, characterized in that: The mass ratio of the zeolite imidazolate framework material to the iron dimer is 1:(0.5-2).

7. The preparation method according to claim 4, characterized in that: The high temperature calcination temperature is 900-1000°C; And / or, the high temperature calcination time is 2 to 4 hours.

8. A method for catalytic decomposition of peroxide, characterized in that: The concave structure interlayer coupled iron diatomic nanozyme described in any one of claims 1 to 3 is used as a catalyst to catalyze the decomposition of peroxide.

9. The method according to claim 8, characterized in that The catalysis is carried out at a pH of 3 to 6; And / or, the catalysis is carried out at a temperature of 30-50°C.

10. A wound repair material, characterized in that: It includes the concave structure interlayer coupled iron diatomic nanozyme as described in any one of claims 1 to 3.